Effects of canrenone on aorta and right ventricle of the rat

Journal of Cardiovascular Pharmacology

Volumn 37, Issue 5, 2001, Pages 540-547

  Cargnelli, Gabriella ^a,b   Trevisi, Lucia ^a   Debetto, Patrizia ^a   Luciani, Sisto ^a   Bova, Sergio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Department of Pharmacology and Anesthesiology ^*  (Italy)

Author keywords

Canrenone; Na+ K+ ATPase; Negative inotropic effect; Ouabain; Vasorelaxation

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM CHANNEL; CALCIUM ION; CANRENONE; DRUG METABOLITE; OUABAIN; PHENYLEPHRINE; POTASSIUM ION; SEROTONIN; SPIRONOLACTONE;

ANIMAL CELL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; HEART DEPOLARIZATION; HEART RIGHT VENTRICLE; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ALDOSTERONE ANTAGONISTS; ANIMALS; AORTA, THORACIC; CALCIUM; CANRENONE; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART VENTRICLES; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL CONTRACTION; OUABAIN; PHENYLEPHRINE; RATS; RATS, WISTAR;

EID: 0035032423     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200105000-00006     Document Type: Article

References (28)

1. Spironolactone and canrenoate-K: Relative potency at steady state
2. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
3. Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure?
4. Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients
5. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism
6. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients
7. Effects of adding spironolactone to an ACE inhibitor in chronic congestive heart failure secondary to coronary artery disease
8. Aldosterone antagonism in heart failure
9. Dose-related cardiovascular effects of spironolactone
10. Anti-hypertensive effect of canrenone in a model where endogenous ouabain-like factors are present
11. + pump inhibition after saline infusion in essentially hypertensive subjects: Effect of canrenone administration
12. Canrenone as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase
13. + pump in human red blood cells
14. Effect of canrenone on the disturbance of cation handling induced by ouabain in macrophages and vascular smooth muscle cells
15. Peripheral action of spironolactone: Plethysmographic studies
16. Spironolactone inhibition of contraction and calcium channels in rat portal vein
17. Na-Ca exchange and tension development in guinea-pig aorta
18. 2+ exchange
19. Do canrenone and 6,7-dihydroxylated derivatives compete with ouabain at the same site on Na,K-ATPase?
20. Sodium-calcium interactions in mammalian smooth muscle
21. Na/Ca exchange and tension development in vascular smooth muscle: Effect of amiloride
22. Effect of subthreshold ouabain on the tone of guinea-pig aortic strips following repeated noradrenaline stimulation
23. Molecular mechanism of cGMP-mediated smooth muscle relaxation
24. Effects of sodium nitroprusside on cytosolic calcium levels in vascular smooth muscle
25. Low concentrations of ouabain increase cytosolic free calcium concentration in rat vascular smooth muscle cells
26. 3H]desmethoxyverapamil binding sites in vascular smooth muscle
27. Calcium channel antagonist effects of spironolactone, an aldosterone antagonist
28. Negative inotropic effect of aldosterone antagonists in isolated human and guinea-pig heart